Perlmutter Cancer Center

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Previously Treated Participants With Metastatic Tnbc, Hr+/her2- Or Her2+ Breast Cancer, Endometrial Cancer, Or Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer
• Age: Between 18 Year(s) - 100 Year(s)
• Gender: Female

• Other Inclusion Criteria:
  

  1. Participant has proven recurrent or advanced solid tumor and has disease progression after treatment with available anti-cancer therapies known to confer benefit or is intolerant to treatment.
  2. Participant must have cardiac left ventricular ejection fraction =50%
  3. Participant must have adequate organ function within 14 days prior to cycle 1, day 1 of treatment
  4. ER+ breast cancer: must have had prior hormonal therapy
  5. TNBC: must have had prior chemotherapy

  
  

You may not be eligible for this study if the following are true:

• 1. Participant has had major surgery within 28 days of starting study treatment, systemic anticancer therapy within the time period of 28 days.
  2. Has a diagnosis of additional malignancy that required active treatment.
  3. Participants with human immunodeficiency virus (HIV) infection are excluded from study entry. An HIV test is required during Screening.